Abstract
A graph plot (GP) method using 123I-N-isopropyl-p-iodoamphetamine (123I-IMP) has been proposed as a simple and non-invasive estimation of quantitative cerebral bloodflow (CBF). A regression equation for the GP method was estimated by the data of resting state. Therefore, the accuracy of CBF values in high flow range may be an underestimated possibility in this method.The aim of this study was to formulate a new regression equation for the GP method by the data of resting state and acetazolamide (ACZ) challenge, and to clarify the accuracy of it. The images of 26 consecutive patients who underwent both 123I-IMP chest radioisotope-angiography (RIA) and single photon emission computed tomography (SPECT) examinations were used to construct the new regression equation. Examinations of the resting state and ACZ challenge were performed in different days. All patients were analyzed by both the GP method and autoradiography (ARG) method which is the conventional examination with the one-point arterial blood sampling. A linear regression equation between the index of the input function was obtained by the GP method and CBF value of ARG. The linear regression equation based on the resting data was compared with the equation based on the resting and ACZ challenge (rest+stress) data. Goodliner correlation was obtained between the index of the input function obtained by the GP method and CBF value of the ARG method in the rest+stress state (y=2.75x+15.1, r=0.78). In contrast, correlation results between the index of the input function obtained by the GP method and CBF value of the ARG method in the resting state was expressed as y=2.28x+18.4, r=0.54 rCBF values based on the resting data was 20% underestimated in the high flow range compared with values based on the rest+stress data. The new linear regression equation for the GP method is useful for clinical study. Key words: non-invasive cerebral blood flow measurement method, graph plot (GP), autoradiography (ARG), 123I-N-isopropyl-p-iodoamphetamine (123I-IMP).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.